Crossmark

Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-vitro, ex-vivo and in-vivo pharmacokinetic evaluation

Crossref DOI link: https://doi.org/10.1007/s13346-023-01342-7

Published Online: 2023-04-17

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ateeq, Mohd Aman Mohd

Aalhate, Mayur

Mahajan, Srushti

Kumar, Gogikar Shiva

Sen, Sibu

Singh, Hoshiyar

Gupta, Ujala

Maji, Indrani

Dikundwar, Amol

Guru, Santosh Kumar

Singh, Pankaj Kumar https://orcid.org/0000-0001-8462-2170
License Information

Text and Data Mining valid from 2023-04-17

Version of Record valid from 2023-04-17
More Information

Article History

Accepted: 24 March 2023

First Online: 17 April 2023

Change Date: 4 May 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s13346-023-01356-1

Declarations

:

: All institutional and national guidelines for the care and use of laboratory animals were followed.

: The authors declare no competing interests.

Updates are available Correction dated 2023-05-04

Click to view Correction: https://doi.org/10.1007/s13346-023-01356-1